Category: Service Provider
Service Provider
Sales is seen as personality-dependent. What attributes truly make the difference between top-performing reps and everyone else?
Recently, my daughter and I drove by a BMW dealership.
"What does BMW stand for?" she asked.
"Bayerische Motoren Werke," I told her (or something close to that). "It's German."
"If I worked for them, I would make a sign that said 'Love Your Ride.'" She fanned her hand in front of her, visualizing it.
"That's very good. Maybe someday you'll be in marketing. That's the kind of thing they do in marketing."
"No!" She bounced upright in her seat. "I want to sell stuff!"
"Why?" I asked, bemused at her reaction.
"Because it's fun," she said.
Career seekers in the medical device industry should leverage their LinkedIn profiles to land a job in medical device sales.
Having a professional LinkedIn profile is a must if you are seeking a job in medical device sales. You can simultaneously promote your current business and open yourself to new opportunities.
If you want to be found by an enterprising recruiter who may have a great job opportunity for you, you need to make yourself easy to be found. Here are a few ways to do it:
Eric Raciti, a partner at IP law firm Finnegan, explains the U.S. Supreme Court's decision in Bilski v. Kappos regarding patenting a business method, and discusses its implications for the medical device industry.
In late June, the U.S. Supreme Court handed down a decision in Bilski v. Kappos, affirming a lower court's ruling that business methods cannot be patented.
MassDevice asked Eric Raciti, a partner at international IP law firm Finnegan, to explain the ruling and its implications for the medical device industry. Raciti also discusses whether the industry's reputation for litigiousness is deserved and how fledgling device makers should go about protecting their intellectual property:
Social media offer the most flexible, rapid and transformative communications venue to communicate a medical device company's approach to accountable care and other issues.
By John Smith
Fresh off the collapse of a merger with WuXi PharmaTech, Charles River Laboratories International Inc. expedites a $300 million share repurchasing plan and takes out a $750 million credit line.
Charles River Laboratories International Inc. (NYSE:CRL), fresh from the collapse of a proposed, $1.6 billion merger with WuXi PharmaTech (Cayman) Inc. (NYSE:WX), plans to accelerate a $300 million stock buyback and took out a $750 million credit line.
The Wilmington, Mass.-based contract research organization said the repurchasing plan will see it buy back 6 million shares initially, with the final number to be determined based on a discounted price based on its daily volume-weighted average price during a a six-month-or-less period as determined by Morgan Stanley & Co. Inc., which is brokering the buyback.
It must be cold in Cupertino, because I finally broke down and bought an iPhone. Here's why, and how medical device makers can use Apple's example in their own marketing efforts.
Well, they must be wearing sweaters in Cupertino because I just purchased an iPhone. I'm the one who went public in my last blog about taking a stand against the Apple brand. When asked what changed, I was finding it hard to explain, especially since I didn't even need a new phone. So to understand how I finally became an Apple convert, I went online for the answer.
A primer on the Food & Drug Administration's definition and classification of medical devices.
According to the Food & Drug Administration, a medical device is "an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including a component part, or accessory which is:
